| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | £ 0.00 | £ 0.00 | £ 0.00 | £ 0.00 | £ 118.35K |
| Gross Profit | £ -35.30K | £ -63.88K | £ -37.61K | £ -118.00K | £ 118.35K |
| Operating Income | £ -2.54M | £ -2.28M | £ -3.06M | £ -3.03M | £ -6.59M |
| EBITDA | £ -2.51M | £ -2.61M | £ -3.02M | £ -2.91M | £ -8.70M |
| Net Income | £ -1.81M | £ -2.48M | £ -2.92M | £ -3.81M | £ -8.17M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | £ 1.35M | £ 236.90K | £ 208.48K | £ 667.81K | £ 1.65M |
| Total Assets | £ 1.88M | £ 977.01K | £ 2.72M | £ 3.97M | £ 6.00M |
| Total Debt | £ 0.00 | £ 0.00 | £ 0.00 | £ 111.00 | £ 700.00 |
| Net Debt | £ -1.35M | £ -236.90K | £ -208.48K | £ -667.70K | £ -1.65M |
| Total Liabilities | £ 1.19M | £ 1.52M | £ 1.67M | £ 1.45M | £ 1.58M |
| Stockholders' Equity | £ 686.86K | £ -542.86K | £ 1.06M | £ 2.52M | £ 4.41M |
| Cash Flow | |||||
| Free Cash Flow | £ -2.37M | £ -1.77M | £ -1.36M | £ -2.45M | £ -4.88M |
| Operating Cash Flow | £ -2.37M | £ -1.77M | £ -1.36M | £ -2.35M | £ -4.83M |
| Investing Cash Flow | £ 6.91K | £ 1.29M | £ 188.76K | £ -77.42K | £ -50.28K |
| Financing Cash Flow | £ 3.43M | £ 500.02K | £ 722.10K | £ 1.55M | £ 702.05K |
ImmuPharma PLC (DE:25I)
FRANKFURT:25I
